2026年 · 第42卷第08期

There are about 11.9 million new strokes worldwide every year, of which cerebral hemorrhage accounts for about 28%^[1,2]。 The onset of cerebral hemorrhage is acute, the condition is severe, the prognosis is poor, more than 1/3 of patients die within 1 month after the onset of cerebral hemorrhage^[1]Its 30-day mortality rate is about 3 times that of ischemic stroke^[3]。 For a long time, effective treatments for cerebral hemorrhage have been relatively limited, and most previous clinical trials have failed to demonstrate that interventions can stably improve patient functional outcomes. In recent years, some high-quality studies have obtained positive results in the fields of clustered management, intensive blood pressure reduction, anticoagulation reversal, and minimally invasive hematoma removal, suggesting that early and standardized active intervention may improve the clinical outcome of patients^[4]。 This guide focuses on hypertensive intracerebral hemorrhage (HICH), the most common spontaneous cerebral hemorrhage in China and controversial in diagnosis and treatment. The prevention and treatment of HICH requires multi-disciplinary collaboration such as emergency department, neurosurgery, neurology, imaging, critical care and rehabilitation medicine. In 2020, multidisciplinary experts jointly formulated the "Chinese Multidisciplinary Diagnosis and Treatment Guidelines for Hypertensive Intracerebral Hemorrhage", which provides an important reference for standardizing the diagnosis and treatment of HICH^[5]。 In view of recent research progress and the continuous accumulation of evidence-based evidence, it is necessary to integrate the latest results and transform them into more practical and actionable clinical practice recommendations. Therefore, it is of great significance to formulate the Guidelines for Multidisciplinary Diagnosis and Treatment of Hypertensive Intracerebral Hemorrhage (2026 Edition) based on the actual medical situation in China.